Vanguard Group Inc Foghorn Therapeutics Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,731,979 shares of FHTX stock, worth $15.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,731,979
Previous 1,059,485
63.47%
Holding current value
$15.3 Million
Previous $6.09 Million
164.67%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding FHTX
# of Institutions
80Shares Held
33.3MCall Options Held
8.7KPut Options Held
2.4K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$112 Million20.03% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$46.9 Million1.57% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.03MShares$26.8 Million0.52% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$20.3 Million0.01% of portfolio
-
Euclidean Capital LLC New York, NY1.57MShares$13.9 Million1.62% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $368M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...